Pancreatic Cancer Research

ResearcherUniversity of PardubiceActive in the last 2 years

Ondřej Peterka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9358-9138; OpenAlex author ID A5013544524. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 5

  1. Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancreatic cancer patients using RP-UHPLC/MS/M… Co-author DOI 10.1007/s00216-025-06151-0↗
  2. RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. First author DOI 10.1016/j.aca.2025.344952↗
  3. Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. Co-author DOI 10.1038/s43856-026-01445-5↗
  4. HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer. Co-author DOI 10.1016/j.aca.2023.342144↗
  5. Lipidomic profiling of human serum enables detection of pancreatic cancer. Co-author DOI 10.1038/s41467-021-27765-9↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michal Holčapek · 5 shared papers, 2022–2026 · strength 1.17
  2. Bohuslav Melichar · 4 shared papers, 2022–2026 · strength 0.94
  3. Martin Loveček · 3 shared papers, 2026 · strength 0.83
  4. Beatrice Mohelníková-Duchoňová · 3 shared papers, 2026 · strength 0.83
  5. Zuzana Lásko · 3 shared papers, 2024–2026 · strength 0.82
  6. Petr Karásek · 2 shared papers, 2022–2026 · strength 0.35
  7. Denise Wolrab · 2 shared papers, 2022–2024 · strength 0.34
  8. Milan Vošmik · 1 shared paper, 2026 · strength 0.24
  9. Jan Trna · 1 shared paper, 2026 · strength 0.24
  10. Pavel Škrha · 1 shared paper, 2022 · strength 0.11
  11. Jan Škrha · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.